CRNX - Crinetics Pharmaceuticals EPS misses by $0.04 May, 06 2021 05:12 PM Crinetics Pharmaceuticals Inc. Crinetics Pharmaceuticals (CRNX): Q1 GAAP EPS of -$0.69 misses by $0.04.Cash, cash equivalents and investments of $150.7MPress Release For further details see: Crinetics Pharmaceuticals EPS misses by $0.04